Tag Archives: CMS

Pharma Revenues, Health Expenditures Set to Increase

Healthcare spending will rise modestly in the US over the next decade, as economic growth picks up, health reform provides expanded coverage, and the population continues to age, according to an annual analysis from the Centers for Medicare and Medicaid Services (CMS). These trends similarly will boost expenditures for prescription drugs, but not as quickly […]
Posted in healthcare, Regulatory | Also tagged , , , | Leave a comment

CMS taps IT firm CGI for Sunshine Act Data Dump

Speaking at CBI’s Sunshine & Aggregate Spend Conference in Washington DC on Tuesday, Shantanu Agrawal, director, data sharing and partnership group, center for program integrity, CMS, said the agency hired IT company CGI to build the software platform to be used for publishing pharma payments to physicians under the Sunshine Act provisions, now re-branded “open […]
Posted in Agency Insight, Deals, E-Media, FDA, healthcare, People, Technology | Also tagged , , , , , , , , , , , , , , | Leave a comment

Your 2014 Medicaid Sales & Marketing Plans

by Tom Norton If you are an Rx regional sales director or a product marketing manager, I have a somewhat provocative question for you:  How exactly are you planning your 2014 Medicaid strategy?
Posted in Advertising, Guest Blog, healthcare, Legal, Market Access, Marketing, pricing, Regulatory, Sales, Strategy | Also tagged , , , , , , , , , | Leave a comment

Drug Utilization Under Managed Medicaid

Cash-strapped states are shifting patients from traditional fee-for-service Medicaid coverage to managed Medicaid plans. The IMS Institute of Healthcare Informatics took an early look at how this trend effects prescription drug utilization.
Posted in Strategy | Also tagged , , , , , , , | Leave a comment

Questions About the 2013 Implementation of IPAB

by Tom Norton With the general election behind us, the anticipated avalanche of ObamaCare regulations has begun.  Last week, it was reported that more than 13,000 pages of rules and regulations have been issued by HHS since Nov. 6th.   A huge amount of activity, to be sure, but as stated, not surprising.  That’s because the […]
Posted in FDA, healthcare, Legal, Market Access, pricing, Regulatory | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta